Rick Wise
Stock Analyst at Stifel
(4.00)
# 532
Out of 5,245 analysts
273
Total ratings
58.11%
Success rate
8.32%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Buy | $105 → $90 | $76.83 | +17.14% | 3 | May 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $110 → $105 | $85.50 | +22.81% | 17 | Apr 29, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $85 | $57.78 | +47.11% | 20 | Apr 21, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $120 | $87.41 | +37.28% | 22 | Apr 17, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $220 → $250 | $234.34 | +6.68% | 9 | Apr 15, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $64.23 | +52.58% | 4 | Feb 5, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $85.78 | +28.24% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $37.01 | +24.29% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $2.78 | +7.91% | 10 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $4.32 | +85.19% | 6 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $70 | $73.83 | -5.19% | 7 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $210 → $215 | $147.63 | +45.63% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $29.49 | +35.64% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $18.40 | +8.73% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $78.60 | +33.59% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $22.46 | +104.81% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $19.18 | +30.34% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.56 | +221.54% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $37.23 | +47.73% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $21.64 | +29.39% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $28.29 | +69.67% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $316.48 | +39.03% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $438.10 | +39.24% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $178.81 | +6.26% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $6.83 | +75.70% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $97.75 | -23.27% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $14.97 | +60.37% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $24.61 | +1.58% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $52.39 | +113.78% | 5 | Oct 2, 2020 |
Solventum
May 6, 2026
Maintains: Buy
Price Target: $105 → $90
Current: $76.83
Upside: +17.14%
Zimmer Biomet Holdings
Apr 29, 2026
Maintains: Buy
Price Target: $110 → $105
Current: $85.50
Upside: +22.81%
Boston Scientific
Apr 21, 2026
Maintains: Buy
Price Target: $90 → $85
Current: $57.78
Upside: +47.11%
Abbott Laboratories
Apr 17, 2026
Maintains: Buy
Price Target: $145 → $120
Current: $87.41
Upside: +37.28%
Johnson & Johnson
Apr 15, 2026
Maintains: Hold
Price Target: $220 → $250
Current: $234.34
Upside: +6.68%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $64.23
Upside: +52.58%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $85.78
Upside: +28.24%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $37.01
Upside: +24.29%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $2.78
Upside: +7.91%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $4.32
Upside: +85.19%
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $73.83
Upside: -5.19%
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $147.63
Upside: +45.63%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $29.49
Upside: +35.64%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $18.40
Upside: +8.73%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $78.60
Upside: +33.59%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $22.46
Upside: +104.81%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $19.18
Upside: +30.34%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.56
Upside: +221.54%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $37.23
Upside: +47.73%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $21.64
Upside: +29.39%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $28.29
Upside: +69.67%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $316.48
Upside: +39.03%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $438.10
Upside: +39.24%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $178.81
Upside: +6.26%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $6.83
Upside: +75.70%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $97.75
Upside: -23.27%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $14.97
Upside: +60.37%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $24.61
Upside: +1.58%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $52.39
Upside: +113.78%